Replies to post #222567 on Biotech Values

[DewDiligence]

DVAX—Maybe it's not over yet? Up to AZN now.

The AZD1419 program is asthma is almost certainly done. The last sentence in the passage you excerpted from the 8-K filing is boilerplate language.